US20130226077A1 - Hypothermia Devices and Methods - Google Patents
Hypothermia Devices and Methods Download PDFInfo
- Publication number
- US20130226077A1 US20130226077A1 US13/860,426 US201313860426A US2013226077A1 US 20130226077 A1 US20130226077 A1 US 20130226077A1 US 201313860426 A US201313860426 A US 201313860426A US 2013226077 A1 US2013226077 A1 US 2013226077A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- cavity
- pressure
- delivery member
- peritoneal cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
- A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F7/123—Devices for heating or cooling internal body cavities using a flexible balloon containing the thermal element
Definitions
- hypothermia has been shown to provide distinct medical benefits to myocardial infarction, traumatic brain injury, stroke, cardiac arrest and other patients by limiting the size of the infarction and related tissue injury if initiated soon enough and if the level of cooling is significant enough.
- initiation of and depth of cooling have made practical application of the technology quite challenging, particularly in an ambulance or other emergency settings in the field. Initiation of cooling, for example, is a major issue since most technologies require sophisticated machinery that would be difficult to place in ambulance, so the patient, at best, receives the hypothermic benefit some time after they reach the hospital.
- the depth of cooling is a major issue due to surface area limitations, complications (such as intense shivering response) and patient access issues (once the blanket is on, it may be difficult to access the patient).
- hypothermia may be induced by cooling the interior of the subject's body, such as by accessing the vasculature or an internal cavity. See, e.g., U.S. Pat. No. 5,752,929; U.S. Pat. No. 5,709,654 and US 2007/0106247.
- Embodiments of the invention provide apparatus, systems and methods for achieving therapeutic hypothermia using minimally invasive access of the peritoneal cavity or other body cavity.
- Such embodiments can use minimally invasive methods to deliver and circulate hypothermic solutions to the peritoneal or other body cavity to reduce body temperature to a selected level for treatment of a number of medical conditions where there is diminished perfusion to one or more locations in the body.
- Such conditions can include various cardiac conditions including myocardial infarction and cardiac arrest; cerebral conditions including stroke and head trauma; and various hemorrhagic events due to arterial dissection or rupture or trauma.
- hypothermic regimens e.g., temperature and rate of cooling
- particular conditions e.g., stroke vs. myocardial infarction so as to reduce the amount of ischemic reperfusion injury to vital organs resulting from the particular ischemic event.
- some embodiments can have hypothermic regimens for various surgical procedures to reduce the amount of post-surgical inflammation and to provide a tissue protective effect so as to extend the operating times for procedures that require reduced perfusion at the surgical site or throughout the body.
- hypothermic regimens for various surgical procedures to reduce the amount of post-surgical inflammation and to provide a tissue protective effect so as to extend the operating times for procedures that require reduced perfusion at the surgical site or throughout the body. Examples of the latter application include open-heart procedures where the heart can be cooled to allow for longer periods during which the heart is arrested and neurosurgical procedures to provide a neuro-protective effect for tissue at or near the operative site.
- hypothermic regimen can be made by the user from a database of regimens stored in memory resources within a system control unit (e.g., a console) or otherwise electronically coupled to the system either directly or wirelessly.
- the hypothermic regimen can be stored in a flash memory or other non-volatile memory device coupled to a disposable catheter set or kit used by the system. The memory device could then interface and upload the regimen to the control device, for example a docking station that the flash memory device plugs in to RF and other wireless interfaces to the system control device using BLUE TOOTH or another protocol are also contemplated.
- peritoneal therapeutic solutions to oxygenate ischemic tissue, reduce reperfusion injury, and increase blood pressure by exerting a compressive force against the peritoneal or other body cavity vasculature.
- peritoneal therapeutic solutions can include various peritoneal dialysis solutions which can comprise nutrients and one or more reperfusion injury protective agents.
- the solution can comprise oxygenated solutions such as oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body.
- oxygenated solutions such as oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body.
- the solution need not be chilled and can actually be warmed.
- embodiments of the invention can be configured as a portable body cavity infusion/hypothermic system that can be readily transported in an ambulance, carried and used at a trauma scene by EMT's, military medics and emergency room personnel.
- one or more components of the system can include a handle, or the entire system can be integrated into an assembly having a handle.
- embodiments of a portable system can be configured for ease of use so as to require minimal set up time and manual dexterity by medical personnel.
- embodiments of the system can use a subcutaneous access device that uses a stop or other means to control the depth of penetration into subcutaneous tissue so that the user need not have to precisely position the access device.
- This access device can be used in conjunction with an infusion catheter having a sensor configured to alert the user when the catheter has entered the peritoneal cavity so as to minimize or eliminate the risk of injuring a peritoneal organ.
- the infusion catheter can make use of quick connections for rapid connection to liquid and gas sources, fluid collection devices and other system components.
- the subsequent infusion and thermal control of fluids can then be automated through use of a computer controller or other electronic controller. In use, such embodiments provide a system with a fast set up time, high degree of reproducibility, and requires minimal dexterity and training of medical personnel.
- One aspect of the invention provides a method of providing hypothermia to a patient.
- the method includes the steps of inserting a fluid delivery member into a peritoneal cavity of the patient; delivering hypothermia fluid from a fluid source into the peritoneal cavity through the delivery member; and limiting fluid pressure within the peritoneal cavity without providing feedback control to the fluid source.
- the limiting step includes the step of extracting fluid from the peritoneal cavity when the pressure reaches a predetermined pressure, such as, e.g., by opening a pressure relief valve at the predetermined pressure.
- the limiting step can include the step of limiting pump outlet pressure such as, e.g., by limiting torque on a moving pump component.
- the step of limiting fluid pressure can include the step of limiting height of the container over the patient.
- the delivering step includes the step of commencing delivery of fluid through the delivery member automatically when an outlet port of the delivery member enters the peritoneal cavity.
- the method may also include the step of activating a heat exchange element within the peritoneal cavity and/or cooling the fluid in the cavity, such as by using an endothermic reaction or using a compressed gas.
- the method includes the step of cycling a fixed volume of fluid into and out of the peritoneal cavity.
- the fluid includes a hypertonic ice slurry and a hypotonic cold fluid.
- the hypertonic ice slurry and a hypotonic cold fluid together may be isotonic.
- the fluid delivery member may be inserted into the peritoneal or other cavity in different ways in different embodiments.
- the inserting step includes the step of inserting the fluid delivery member transgastrically or transrectally.
- the method includes the step of measuring patient temperature in e.g., the patient's trachea, esophagus and/or bladder.
- the measured temperature may be used to control fluid flow and/or temperature.
- the method includes the step of providing automated circulation to the patient with a CPR machine. Some embodiments also include the step of contacting an exterior surface of the patient with a cooling blanket.
- a hypothermia system including: a fluid source; a fluid delivery member adapted to be inserted into a peritoneal cavity of a patient; and a cavity pressure limiter adapted to limit fluid pressure within the peritoneal cavity without providing feedback control to the fluid source.
- Some embodiments also include a fluid extraction member adapted to extract fluid from the peritoneal cavity.
- the cavity pressure limiter has a pressure relief valve controlling flow of fluid through the fluid extraction member.
- the fluid extraction member may also have a weight at an inlet port.
- the fluid source includes a pump and the cavity pressure limiter includes a torque limiter (such as a clutch plate) in the pump.
- the fluid delivery member may also include a multi-lumen trocar.
- Some embodiments of the invention include a heat exchange element supported by the fluid delivery member.
- the fluid source may include a hypertonic ice slurry and a hypotonic cold fluid, combinations of which may be isotonic.
- Embodiments of the invention may also include delivery tools for the fluid delivery member, such as a transgastric delivery tool or a transrectal delivery tool. Some embodiments may also include a patient temperature sensor mounted on an endotracheal cuff, an esophageal catheter and/or a bladder catheter.
- Some embodiments may also have a CPR machine adapted to provide automated circulation to the patient and/or a cooling blanket.
- FIG. 1 shows a hypothermia therapy system according to certain embodiments of the invention.
- FIG. 2 shows a hypothermia therapy system according to another embodiment of the invention employing a heating/cooling element.
- FIG. 3 shows a hypothermia therapy system according to an embodiment of the invention employing an infusion pump and a pressure-responsive valve.
- FIG. 4 shows a hypothermia therapy system according to another embodiment of the invention employing a pressure-responsive valve.
- FIG. 5 shows a hypothermia therapy system according to an embodiment of the invention employing transgastric access to a patient cavity.
- FIG. 6 shows temperature sensors on an endotracheal tube for use with a hypothermia therapy system according to embodiments of the invention.
- FIG. 7 shows temperature sensors on an esophageal catheter for use with a hypothermia therapy system according to embodiments of the invention.
- FIG. 8 shows a temperature sensor on a urethral catheter for use with a hypothermia therapy system according to embodiments of the invention.
- FIG. 9 shows a hypothermia system combined with a CPR resuscitation system according to an embodiment of the invention.
- FIG. 10 shows a hypothermia system combined with an external cooling blanket according to an embodiment of the invention.
- FIGS. 11 and 12 show an embodiment of the invention employing a trocar providing access for infusion and extraction lumens.
- Embodiments of the invention provide apparatus, systems and methods for providing therapeutic hypothermia through minimally invasive access to the peritoneal cavity. Many embodiments provide a system for providing hypothermia, resuscitation or other treatment in response to stroke, myocardial infarction, blood loss or any condition resulting in decreased perfusion to one or more locations in the body, including both internal organs and the extremities. Embodiments of the invention may also be used with cadavers to preserve organs for later transplant. The term “patient” may be used herein to denote either living subjects requiring hypothermia therapy or dead subjects whose organs need to be preserved for transplant.
- FIG. 1 shows a system 10 for the delivery of hypothermic or other fluid from a fluid source 20 through a fluid delivery member 16 (including, e.g., a catheter) to a peritoneal or other tissue cavity 12 of a patient 14 .
- the delivered fluid comprises a solution for the delivery of a medical treatment such as hypothermic or resuscitative treatment.
- Suitable fluids can comprise various saline solutions (e.g., ringers lactate), various peritoneal dialysis fluids including nutritive based peritoneal dialysis fluid (e.g., those containing dextrose and other sugars), and fluorocarbon solutions configure for oxygen transport and artificial blood solutions known in the art.
- the solution can also include one or more freezing point depression compounds (e.g., NaCl) allowing the solution to be cooled below the freezing point of water to allow for faster cooling when so desired.
- freezing point depression compounds e.g., NaCl
- the delivered fluid can contain one or more medicaments for treatment of myocardial infarction, cardiac arrest or other severe cardiac condition, stroke, shock, reperfusion injury or other medical conditions.
- medicaments for treatment of myocardial infarction, cardiac arrest or other severe cardiac condition, stroke, shock, reperfusion injury or other medical conditions.
- Specific families of medicaments can include vasoconstrictors, hemolytic compounds (e.g., TPA, streptokinase and like compounds), anticoagulants, coagulants, calcium channel blockers, antibiotics, manitols.
- the delivered fluid can be configured to have resuscitative effects for treatment of heart attack, stroke, or severe blood loss. It can also have various agents known in the art for treatment of reperfusion injury.
- the delivered amount of a particular medicament can be titrated to the patient's weight and condition.
- the dose of particular compounds can both be delivered as bolus with the initial bolus of hypothermic solution and also on a continuous basis.
- the delivery rate of a particular medicament or group of medicaments can also be controlled responsive to the patient's temperature, blood pressure, heart rate or other vital sign monitored manually, by system 10 , or by other monitoring means.
- the delivered fluid can also comprise oxygenated solutions such as supersaturated saline, oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body.
- oxygenated solutions can be pre-oxygenated or can be oxygenated in the fluid source 20 or outside of it using oxygen gas sources described herein.
- the delivered fluid can also include contrast media to allow for imaging by x-ray, MRI, ultrasound, and other imaging modalities known in the art.
- a phase change solution such as a slurry of ice, may be used within the cavity.
- Additives to the infusate may also be used to increase the cooling capacity of the fluid.
- One such additive is propylene glycol, but any safe compound may be used so long as it leads to greater cooling capacity.
- a hypertonic ice slurry solution may be delivered to the patient's cavity followed by a hypotonic cold fluid with a net result of an isotonic fluid.
- the fluid source can include a patient cavity pressure limiter adapted to limit fluid pressure within the peritoneal or other cavity to which fluid delivery member 16 delivers fluid without providing feedback information or control to the fluid source.
- the cavity pressure limiter could include a bag support (not shown) that limits the height of the bag over the patient cavity to which the fluid is being delivered.
- the cavity pressure limiter could include a controller controlling pump output pressure or a torque limiter (such as a clutch) limiting the output torque of a moving pump element.
- a high-flow, low-pressure pump may also be operated such that its output cannot exceed a predetermined pressure, such as, e.g., 10 cm H 2 O.
- the fluid delivery member 16 When used to treat a patient, the fluid delivery member 16 is inserted into the patient's peritoneal cavity 12 or other cavity.
- a trocar or other suitable instrument may be used to aid insertion and sealing of the insertion site.
- an insertion sensor such as described in U.S. patent application Ser. No. 12/098,355 may also be used.
- hypothermia fluid is delivered from the fluid source 20 to the patient's cavity 12 through the delivery member. Fluid pressure within the cavity is limited without providing pressure feedback information or control to the fluid source.
- the system may be used to infuse an initial bolus of fluid, or liquid/particulate mixture, but then may function as heat-exchanger to simply cool the fluid within the peritoneal cavity with no further fluid infusion and/or extraction required.
- the distal end of the fluid delivery member 16 has a cooling/warming element 22 , such as a heat-exchanger.
- the fluid may be left within the peritoneal cavity at the end of the cooling period or may be extracted. If the fluid is left in the cavity, it may be warmed by the heat-exchanger. Additionally, the fluid may be replaced by warmed fluid at the end of the cooling period and then warmed or cooled in order to achieve the desired rewarming rate.
- a heat-exchange catheter may be placed through or alongside the fluid delivery member within the cavity 12 .
- the catheter itself may contain a cooling/warming apparatus and/or a pumping mechanism to circulate fluid within the cavity without pumping the fluid externally.
- the cooling/warming apparatus may consist of a variety of mechanisms, including circulating fluid or gas, a peltier junction, etc.
- the fluid within the cavity may be cooled by an endothermic reaction which cools the peritoneal cavity via a chemical reaction.
- This reaction may be tailored to be temperature dependent and may be suspended or drastically slowed at the target temperature (typically within the 30-34 degree Celsius range).
- This reaction may also be generated within the fluid-filled cavity by a steady or intermittent infusion of reactive compounds which function to complete the endothermic reaction and lower the cavity temperature. Any endothermic chemical reaction may be used so long as it is biocompatible.
- the bag of fluid instead of requiring the bag of fluid to be prechilled, it may be rapidly cooled using a CO 2 cartridge or other source of compressed gas or endothermic reaction to cool fluid immediately prior to its infusion into the cavity.
- the fluid may be cooled as it enters into the cavity and may be kept at room temperature outside of the body. This relieves the requirement for prechilling and decreases the overall nursing burden.
- a fixed volume of fluid may be used that is safe for all patients (i.e., 1-2 L) and is then automatically cycled to achieve the desired cooling/warming rates, based, e.g., on the temperature of the fluid in the cavity and additional temperature sensors elsewhere in the body.
- the volume of fluid in the cavity can be kept track of by the pump and fluid infusion/extraction may be coupled to ensure that excessive pressures are not generated and excessive volumes are not infused.
- a fixed volume of fluid may be infused and the pressure measured post-infusion. This post-infusion pressure may be maintained throughout the treatment cycle to ensure that a minimum volume of fluid is maintained within the cavity.
- the fluid delivery member includes a fluid infusion line 30 leading from the fluid source 31 , which is shown here as an infusion pump.
- the system also includes a fluid extraction line 32 leading from the patient's peritoneal cavity 12 to a drainage reservoir 34 .
- a pressure-responsive valve 36 (such as a pop-off valve or passive or active check valve), or other pressure limiting mechanism, may be incorporated in line with the infusion and extraction lumens to ensure that once the desired pressure is achieved the infused fluid is shunted back into the fluid path (or into the drainage reservoir) and/or the fluid extracted is immediately shunted outside of the body regardless of pump function.
- these pop-off valves may be present on the inflow lumen, the outflow lumen, or both lumens.
- the pop-off valves may be the only safeguard against over-pressurization, or they may be used in combination with a pressure sensor as a redundant protection mechanism to ensure that the over-pressurization never occurs.
- the device may be capable of performing a diagnostic to check the functionality of both pop-off valves prior to therapy initiation.
- a pop-off valve 40 has been incorporated into a paramedic unit wherein the fluid source is a fixed volume bag 42 .
- This system may be utilized in an ambulance, and the entire bag may be infused in every patient with the excess fluid being shunted directly to a waste reservoir 44 if the target or threshold pressure is exceeded.
- This will allow each patient to receive a maximum volume of fluid in transit, after which the infusion/extraction ports may be connected to the full device in the emergency room (or elsewhere), and the cycling of fluid and monitoring of temperatures and/or pressures may begin.
- the paramedic unit therefore needs to consist only of the infusion catheter 46 , the safety pop-off valve 40 (or other pressure protective mechanism) and a reservoir of fluid 42 (pre-chilled or chilled on demand).
- the fluid delivery member accesses the patient's peritoneal cavity via an incision in the abdominal wall.
- Other means of accessing the peritoneal cavity are within the scope of the invention.
- the fluid delivery member 50 accesses the peritoneal cavity transgastrically to deliver fluid from infusion pump (or other fluid source) 52 via catheter 54 and to (optionally) extract fluid through extraction line 56 to drainage reservoir 58 .
- Other embodiments may employ transrectal access or other natural orifice translumenal access to the peritoneal cavity.
- exhaled air may be used as an indication of core temperature.
- temperature sensors 60 disposed on an endotracheal tube 61 e.g., on the cuff 62 and/or on an interior surface of the lumen 64 ) may be placed within the patient's trachea 66 to measure the temperature of exhaled air to indicate the temperature of the lungs without requiring any invasive sensors.
- One or more temperature sensors may also be disposed in the airway line external to the patient. This information may be used to monitor or control warming or cooling of the patient.
- the difference between inhaled and exhaled air can be correlated to patient core temperature. If an endotracheal tube is not being used, temperature sensors may also be disposed in a mask over the patient's nose and/or mouth.
- FIG. 7 shows an alternative temperature sensor for use with the system of this invention.
- multiple temperature sensors 70 are disposed along an esophageal catheter 72 for monitoring and/or control of the system.
- the use of multiple temperature sensors can help ensure that system control will not be based on an erroneous reading from a single under- or over-inserted sensor. Failure of one temperature sensor to agree with the others indicates that the sensor is in the wrong place.
- FIG. 8 shows yet another temperature sensor for use with the system of this invention.
- a temperature sensor 80 disposed on a urethral catheter 82 is placed within the urethra 84 as shown.
- a retention balloon 86 helps hold the catheter within the bladder 88 in a known manner.
- information from temperature sensor 80 may be used to monitor and/or control the warming or cooling provided by the system of the invention.
- Multiple temperature sensors may be used, as in the embodiment of FIG. 7 .
- the hypothermia system 90 may be combined with a CPR resuscitation system 92 , as shown in FIG. 9 .
- the two devices could, for example, share the same enclosure, battery and microprocessor and could function in unison to resuscitate the patient while providing therapeutic hypothermia.
- peritoneal infusion of cold or warm fluid could be used as an adjunct to other temperature management technologies.
- 2 liters of cold fluid could be infused into the peritoneal cavity via a hypothermia system 100 in order to jump start the cooling process after which external cooling blankets 102 or other hypothermia producing therapies can be implemented, as shown in FIG. 10 .
- the IV fluid may be cooled with an ultrasonic refrigeration method.
- the tissues may be cooled directly via ultrasonic or other energy transmission means.
- ultrasonic cooling incorporated into a helmet for a neuro-protective device.
- These focused cooling technologies may be used to target any organ, though, including the heart, brain, liver, kidneys, etc., or may be used to cool the entire body.
- Tissue penetration and placement of the fluid delivery member can be achieved in any manner known in the art, such as that described in US 2007/0106247, which has been incorporated herein by reference.
- the device may then report entry to the user and/or automatically initiate therapy.
- FIGS. 11 and 12 show one embodiment in which initial access through the abdominal wall 113 to the cavity 112 is obtained with a fill trocar, catheter or needle 110 .
- Infusion tubing 116 leads from a fluid source (not shown to a cap or fluid seal 117 .
- An extraction catheter 118 may be inserted through cap 117 to extract fluid from the cavity, e.g., after a rapid infusion phase of the therapy.
- the distal end 119 and inlet port of the extraction catheter 118 may be weighted to ensure that it lies in the most dependent portion of the peritoneal cavity 112 .
Abstract
A method of providing hypothermia to a patient including the steps of inserting a fluid delivery member into a peritoneal cavity of the patient; delivering hypothermia fluid from a fluid source into the peritoneal cavity through the delivery member; and limiting fluid pressure within the peritoneal cavity without providing feedback control to the fluid source. The invention also provides an apparatus for practicing the method.
Description
- This application is a continuation of pending U.S. application Ser. No. 12/169,566, filed Jul. 8, 2008, which application claims priority under 35 U.S.C. §119 to U.S. Application No. 60/958,717, filed Jul. 9, 2007, the disclosures of which are incorporated by reference as if fully set forth herein.
- All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
- Hypothermia has been shown to provide distinct medical benefits to myocardial infarction, traumatic brain injury, stroke, cardiac arrest and other patients by limiting the size of the infarction and related tissue injury if initiated soon enough and if the level of cooling is significant enough. Both of these limitations—initiation of and depth of cooling—have made practical application of the technology quite challenging, particularly in an ambulance or other emergency settings in the field. Initiation of cooling, for example, is a major issue since most technologies require sophisticated machinery that would be difficult to place in ambulance, so the patient, at best, receives the hypothermic benefit some time after they reach the hospital. Of the technologies that can be initiated in the field, such as cooling blankets, cooling caps, etc., the depth of cooling is a major issue due to surface area limitations, complications (such as intense shivering response) and patient access issues (once the blanket is on, it may be difficult to access the patient).
- In addition to externally applied cooling, hypothermia may be induced by cooling the interior of the subject's body, such as by accessing the vasculature or an internal cavity. See, e.g., U.S. Pat. No. 5,752,929; U.S. Pat. No. 5,709,654 and US 2007/0106247.
- The present invention relates to patient hypothermia systems and methods. Embodiments of the invention provide apparatus, systems and methods for achieving therapeutic hypothermia using minimally invasive access of the peritoneal cavity or other body cavity. Such embodiments can use minimally invasive methods to deliver and circulate hypothermic solutions to the peritoneal or other body cavity to reduce body temperature to a selected level for treatment of a number of medical conditions where there is diminished perfusion to one or more locations in the body. Such conditions can include various cardiac conditions including myocardial infarction and cardiac arrest; cerebral conditions including stroke and head trauma; and various hemorrhagic events due to arterial dissection or rupture or trauma. Particular hypothermic regimens (e.g., temperature and rate of cooling) can be employed to treat particular conditions e.g., stroke vs. myocardial infarction so as to reduce the amount of ischemic reperfusion injury to vital organs resulting from the particular ischemic event.
- Also, some embodiments can have hypothermic regimens for various surgical procedures to reduce the amount of post-surgical inflammation and to provide a tissue protective effect so as to extend the operating times for procedures that require reduced perfusion at the surgical site or throughout the body. Examples of the latter application include open-heart procedures where the heart can be cooled to allow for longer periods during which the heart is arrested and neurosurgical procedures to provide a neuro-protective effect for tissue at or near the operative site.
- Selection of a particular hypothermic regimen can be made by the user from a database of regimens stored in memory resources within a system control unit (e.g., a console) or otherwise electronically coupled to the system either directly or wirelessly. In particular embodiments, the hypothermic regimen can be stored in a flash memory or other non-volatile memory device coupled to a disposable catheter set or kit used by the system. The memory device could then interface and upload the regimen to the control device, for example a docking station that the flash memory device plugs in to RF and other wireless interfaces to the system control device using BLUE TOOTH or another protocol are also contemplated.
- These and related embodiments can also be utilized for patient resuscitation from various ischemic, hemorrhagic events (e.g., stroke or cardiac arrest) as well as shock through the use of peritoneal therapeutic solutions to oxygenate ischemic tissue, reduce reperfusion injury, and increase blood pressure by exerting a compressive force against the peritoneal or other body cavity vasculature. Such therapeutic solutions can include various peritoneal dialysis solutions which can comprise nutrients and one or more reperfusion injury protective agents. Also, the solution can comprise oxygenated solutions such as oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body. For embodiments of the invention used to treat shock, the solution need not be chilled and can actually be warmed.
- Also, many embodiments of the invention can be configured as a portable body cavity infusion/hypothermic system that can be readily transported in an ambulance, carried and used at a trauma scene by EMT's, military medics and emergency room personnel. Thus, one or more components of the system can include a handle, or the entire system can be integrated into an assembly having a handle. Further, as described herein, embodiments of a portable system can be configured for ease of use so as to require minimal set up time and manual dexterity by medical personnel. For example, embodiments of the system can use a subcutaneous access device that uses a stop or other means to control the depth of penetration into subcutaneous tissue so that the user need not have to precisely position the access device. This access device can be used in conjunction with an infusion catheter having a sensor configured to alert the user when the catheter has entered the peritoneal cavity so as to minimize or eliminate the risk of injuring a peritoneal organ. The infusion catheter can make use of quick connections for rapid connection to liquid and gas sources, fluid collection devices and other system components. The subsequent infusion and thermal control of fluids can then be automated through use of a computer controller or other electronic controller. In use, such embodiments provide a system with a fast set up time, high degree of reproducibility, and requires minimal dexterity and training of medical personnel.
- One aspect of the invention provides a method of providing hypothermia to a patient. The method includes the steps of inserting a fluid delivery member into a peritoneal cavity of the patient; delivering hypothermia fluid from a fluid source into the peritoneal cavity through the delivery member; and limiting fluid pressure within the peritoneal cavity without providing feedback control to the fluid source. In some embodiments, the limiting step includes the step of extracting fluid from the peritoneal cavity when the pressure reaches a predetermined pressure, such as, e.g., by opening a pressure relief valve at the predetermined pressure.
- In embodiments in which the fluid source includes a pump, the limiting step can include the step of limiting pump outlet pressure such as, e.g., by limiting torque on a moving pump component. In embodiments in which the fluid source includes a fluid container, the step of limiting fluid pressure can include the step of limiting height of the container over the patient.
- In some embodiments, the delivering step includes the step of commencing delivery of fluid through the delivery member automatically when an outlet port of the delivery member enters the peritoneal cavity. The method may also include the step of activating a heat exchange element within the peritoneal cavity and/or cooling the fluid in the cavity, such as by using an endothermic reaction or using a compressed gas. In some embodiments, the method includes the step of cycling a fixed volume of fluid into and out of the peritoneal cavity.
- In some embodiments, the fluid includes a hypertonic ice slurry and a hypotonic cold fluid. The hypertonic ice slurry and a hypotonic cold fluid together may be isotonic.
- The fluid delivery member may be inserted into the peritoneal or other cavity in different ways in different embodiments. For example, in some embodiments the inserting step includes the step of inserting the fluid delivery member transgastrically or transrectally.
- In some embodiments, the method includes the step of measuring patient temperature in e.g., the patient's trachea, esophagus and/or bladder. The measured temperature may be used to control fluid flow and/or temperature.
- In some embodiments, the method includes the step of providing automated circulation to the patient with a CPR machine. Some embodiments also include the step of contacting an exterior surface of the patient with a cooling blanket.
- Another aspect of the invention provides a hypothermia system including: a fluid source; a fluid delivery member adapted to be inserted into a peritoneal cavity of a patient; and a cavity pressure limiter adapted to limit fluid pressure within the peritoneal cavity without providing feedback control to the fluid source. Some embodiments also include a fluid extraction member adapted to extract fluid from the peritoneal cavity. In some such embodiments, the cavity pressure limiter has a pressure relief valve controlling flow of fluid through the fluid extraction member. The fluid extraction member may also have a weight at an inlet port.
- In some embodiments, the fluid source includes a pump and the cavity pressure limiter includes a torque limiter (such as a clutch plate) in the pump. The fluid delivery member may also include a multi-lumen trocar.
- Some embodiments of the invention include a heat exchange element supported by the fluid delivery member. The fluid source may include a hypertonic ice slurry and a hypotonic cold fluid, combinations of which may be isotonic.
- Embodiments of the invention may also include delivery tools for the fluid delivery member, such as a transgastric delivery tool or a transrectal delivery tool. Some embodiments may also include a patient temperature sensor mounted on an endotracheal cuff, an esophageal catheter and/or a bladder catheter.
- Some embodiments may also have a CPR machine adapted to provide automated circulation to the patient and/or a cooling blanket.
- The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
-
FIG. 1 shows a hypothermia therapy system according to certain embodiments of the invention. -
FIG. 2 shows a hypothermia therapy system according to another embodiment of the invention employing a heating/cooling element. -
FIG. 3 shows a hypothermia therapy system according to an embodiment of the invention employing an infusion pump and a pressure-responsive valve. -
FIG. 4 shows a hypothermia therapy system according to another embodiment of the invention employing a pressure-responsive valve. -
FIG. 5 shows a hypothermia therapy system according to an embodiment of the invention employing transgastric access to a patient cavity. -
FIG. 6 shows temperature sensors on an endotracheal tube for use with a hypothermia therapy system according to embodiments of the invention. -
FIG. 7 shows temperature sensors on an esophageal catheter for use with a hypothermia therapy system according to embodiments of the invention. -
FIG. 8 shows a temperature sensor on a urethral catheter for use with a hypothermia therapy system according to embodiments of the invention. -
FIG. 9 shows a hypothermia system combined with a CPR resuscitation system according to an embodiment of the invention. -
FIG. 10 shows a hypothermia system combined with an external cooling blanket according to an embodiment of the invention. -
FIGS. 11 and 12 show an embodiment of the invention employing a trocar providing access for infusion and extraction lumens. - Embodiments of the invention provide apparatus, systems and methods for providing therapeutic hypothermia through minimally invasive access to the peritoneal cavity. Many embodiments provide a system for providing hypothermia, resuscitation or other treatment in response to stroke, myocardial infarction, blood loss or any condition resulting in decreased perfusion to one or more locations in the body, including both internal organs and the extremities. Embodiments of the invention may also be used with cadavers to preserve organs for later transplant. The term “patient” may be used herein to denote either living subjects requiring hypothermia therapy or dead subjects whose organs need to be preserved for transplant.
-
FIG. 1 shows asystem 10 for the delivery of hypothermic or other fluid from afluid source 20 through a fluid delivery member 16 (including, e.g., a catheter) to a peritoneal orother tissue cavity 12 of apatient 14. In various embodiments, the delivered fluid comprises a solution for the delivery of a medical treatment such as hypothermic or resuscitative treatment. Suitable fluids can comprise various saline solutions (e.g., ringers lactate), various peritoneal dialysis fluids including nutritive based peritoneal dialysis fluid (e.g., those containing dextrose and other sugars), and fluorocarbon solutions configure for oxygen transport and artificial blood solutions known in the art. For aqueous embodiments, the solution can also include one or more freezing point depression compounds (e.g., NaCl) allowing the solution to be cooled below the freezing point of water to allow for faster cooling when so desired. - Also, the delivered fluid can contain one or more medicaments for treatment of myocardial infarction, cardiac arrest or other severe cardiac condition, stroke, shock, reperfusion injury or other medical conditions. Specific families of medicaments can include vasoconstrictors, hemolytic compounds (e.g., TPA, streptokinase and like compounds), anticoagulants, coagulants, calcium channel blockers, antibiotics, manitols. Also in specific embodiments, the delivered fluid can be configured to have resuscitative effects for treatment of heart attack, stroke, or severe blood loss. It can also have various agents known in the art for treatment of reperfusion injury. The delivered amount of a particular medicament can be titrated to the patient's weight and condition. Also, the dose of particular compounds can both be delivered as bolus with the initial bolus of hypothermic solution and also on a continuous basis. The delivery rate of a particular medicament or group of medicaments can also be controlled responsive to the patient's temperature, blood pressure, heart rate or other vital sign monitored manually, by
system 10, or by other monitoring means. - The delivered fluid can also comprise oxygenated solutions such as supersaturated saline, oxygenated fluorocarbon solutions that can be configured to deliver sufficient oxygen to tissue (by gas exchange with peritoneal or other surrounding tissue) to at least partially meet the oxygen demands of the body. Fluorocarbon solutions can be pre-oxygenated or can be oxygenated in the
fluid source 20 or outside of it using oxygen gas sources described herein. The delivered fluid can also include contrast media to allow for imaging by x-ray, MRI, ultrasound, and other imaging modalities known in the art. - A phase change solution, such as a slurry of ice, may be used within the cavity. Additives to the infusate may also be used to increase the cooling capacity of the fluid. One such additive is propylene glycol, but any safe compound may be used so long as it leads to greater cooling capacity. In some embodiments, a hypertonic ice slurry solution may be delivered to the patient's cavity followed by a hypotonic cold fluid with a net result of an isotonic fluid.
- In various embodiments, such as some of those discussed below, the fluid source can include a patient cavity pressure limiter adapted to limit fluid pressure within the peritoneal or other cavity to which
fluid delivery member 16 delivers fluid without providing feedback information or control to the fluid source. For example, in embodiments in which the fluid source is a bag of fluid suspended higher than the patient, the cavity pressure limiter could include a bag support (not shown) that limits the height of the bag over the patient cavity to which the fluid is being delivered. In embodiments in which the fluid source includes a pump, the cavity pressure limiter could include a controller controlling pump output pressure or a torque limiter (such as a clutch) limiting the output torque of a moving pump element. A high-flow, low-pressure pump may also be operated such that its output cannot exceed a predetermined pressure, such as, e.g., 10 cm H2O. - When used to treat a patient, the
fluid delivery member 16 is inserted into the patient'speritoneal cavity 12 or other cavity. A trocar or other suitable instrument may be used to aid insertion and sealing of the insertion site. In some embodiments, an insertion sensor such as described in U.S. patent application Ser. No. 12/098,355 may also be used. After insertion, hypothermia fluid is delivered from thefluid source 20 to the patient'scavity 12 through the delivery member. Fluid pressure within the cavity is limited without providing pressure feedback information or control to the fluid source. - In another embodiment, the system may be used to infuse an initial bolus of fluid, or liquid/particulate mixture, but then may function as heat-exchanger to simply cool the fluid within the peritoneal cavity with no further fluid infusion and/or extraction required. For example, as shown in
FIG. 2 , the distal end of thefluid delivery member 16 has a cooling/warming element 22, such as a heat-exchanger. In this embodiment, the fluid may be left within the peritoneal cavity at the end of the cooling period or may be extracted. If the fluid is left in the cavity, it may be warmed by the heat-exchanger. Additionally, the fluid may be replaced by warmed fluid at the end of the cooling period and then warmed or cooled in order to achieve the desired rewarming rate. As an alternative, a heat-exchange catheter may be placed through or alongside the fluid delivery member within thecavity 12. In this embodiment, the catheter itself may contain a cooling/warming apparatus and/or a pumping mechanism to circulate fluid within the cavity without pumping the fluid externally. The cooling/warming apparatus may consist of a variety of mechanisms, including circulating fluid or gas, a peltier junction, etc. - In yet another embodiment, the fluid within the cavity may be cooled by an endothermic reaction which cools the peritoneal cavity via a chemical reaction. This reaction may be tailored to be temperature dependent and may be suspended or drastically slowed at the target temperature (typically within the 30-34 degree Celsius range). This reaction may also be generated within the fluid-filled cavity by a steady or intermittent infusion of reactive compounds which function to complete the endothermic reaction and lower the cavity temperature. Any endothermic chemical reaction may be used so long as it is biocompatible.
- In yet another embodiment, instead of requiring the bag of fluid to be prechilled, it may be rapidly cooled using a CO2 cartridge or other source of compressed gas or endothermic reaction to cool fluid immediately prior to its infusion into the cavity. In another version of this embodiment, the fluid may be cooled as it enters into the cavity and may be kept at room temperature outside of the body. This relieves the requirement for prechilling and decreases the overall nursing burden.
- In yet another embodiment of the invention, a fixed volume of fluid may be used that is safe for all patients (i.e., 1-2 L) and is then automatically cycled to achieve the desired cooling/warming rates, based, e.g., on the temperature of the fluid in the cavity and additional temperature sensors elsewhere in the body. In this embodiment, the volume of fluid in the cavity can be kept track of by the pump and fluid infusion/extraction may be coupled to ensure that excessive pressures are not generated and excessive volumes are not infused. Alternatively, a fixed volume of fluid may be infused and the pressure measured post-infusion. This post-infusion pressure may be maintained throughout the treatment cycle to ensure that a minimum volume of fluid is maintained within the cavity.
- In the embodiment shown in
FIG. 3 , the fluid delivery member includes afluid infusion line 30 leading from thefluid source 31, which is shown here as an infusion pump. The system also includes afluid extraction line 32 leading from the patient'speritoneal cavity 12 to adrainage reservoir 34. A pressure-responsive valve 36 (such as a pop-off valve or passive or active check valve), or other pressure limiting mechanism, may be incorporated in line with the infusion and extraction lumens to ensure that once the desired pressure is achieved the infused fluid is shunted back into the fluid path (or into the drainage reservoir) and/or the fluid extracted is immediately shunted outside of the body regardless of pump function. With these redundant safeguards, excessive cavity pressure may be prevented without halting further fluid influx and/or shunting fluid out of the peritoneal cavity. In this embodiment, these pop-off valves may be present on the inflow lumen, the outflow lumen, or both lumens. The pop-off valves may be the only safeguard against over-pressurization, or they may be used in combination with a pressure sensor as a redundant protection mechanism to ensure that the over-pressurization never occurs. The device may be capable of performing a diagnostic to check the functionality of both pop-off valves prior to therapy initiation. - In the embodiment shown in
FIG. 4 , a pop-offvalve 40 has been incorporated into a paramedic unit wherein the fluid source is a fixedvolume bag 42. This system may be utilized in an ambulance, and the entire bag may be infused in every patient with the excess fluid being shunted directly to awaste reservoir 44 if the target or threshold pressure is exceeded. This will allow each patient to receive a maximum volume of fluid in transit, after which the infusion/extraction ports may be connected to the full device in the emergency room (or elsewhere), and the cycling of fluid and monitoring of temperatures and/or pressures may begin. The paramedic unit therefore needs to consist only of the infusion catheter 46, the safety pop-off valve 40 (or other pressure protective mechanism) and a reservoir of fluid 42 (pre-chilled or chilled on demand). - In many of the embodiments described above, the fluid delivery member accesses the patient's peritoneal cavity via an incision in the abdominal wall. Other means of accessing the peritoneal cavity are within the scope of the invention. For example, in the embodiment shown in
FIG. 5 , thefluid delivery member 50 accesses the peritoneal cavity transgastrically to deliver fluid from infusion pump (or other fluid source) 52 viacatheter 54 and to (optionally) extract fluid throughextraction line 56 todrainage reservoir 58. Other embodiments may employ transrectal access or other natural orifice translumenal access to the peritoneal cavity. - In some embodiments it may be desirable to monitor the patient's temperature. For example, exhaled air may be used as an indication of core temperature. As shown in
FIG. 6 ,temperature sensors 60 disposed on an endotracheal tube 61 (e.g., on thecuff 62 and/or on an interior surface of the lumen 64) may be placed within the patient'strachea 66 to measure the temperature of exhaled air to indicate the temperature of the lungs without requiring any invasive sensors. One or more temperature sensors may also be disposed in the airway line external to the patient. This information may be used to monitor or control warming or cooling of the patient. Also, the difference between inhaled and exhaled air can be correlated to patient core temperature. If an endotracheal tube is not being used, temperature sensors may also be disposed in a mask over the patient's nose and/or mouth. -
FIG. 7 shows an alternative temperature sensor for use with the system of this invention. In this embodiment,multiple temperature sensors 70 are disposed along anesophageal catheter 72 for monitoring and/or control of the system. The use of multiple temperature sensors can help ensure that system control will not be based on an erroneous reading from a single under- or over-inserted sensor. Failure of one temperature sensor to agree with the others indicates that the sensor is in the wrong place. -
FIG. 8 shows yet another temperature sensor for use with the system of this invention. In this embodiment, atemperature sensor 80 disposed on aurethral catheter 82 is placed within theurethra 84 as shown. Aretention balloon 86 helps hold the catheter within thebladder 88 in a known manner. Once again, information fromtemperature sensor 80 may be used to monitor and/or control the warming or cooling provided by the system of the invention. Multiple temperature sensors may be used, as in the embodiment ofFIG. 7 . - In some embodiments, the
hypothermia system 90 may be combined with aCPR resuscitation system 92, as shown inFIG. 9 . The two devices could, for example, share the same enclosure, battery and microprocessor and could function in unison to resuscitate the patient while providing therapeutic hypothermia. - Additionally, the peritoneal infusion of cold or warm fluid could be used as an adjunct to other temperature management technologies. For example, 2 liters of cold fluid could be infused into the peritoneal cavity via a
hypothermia system 100 in order to jump start the cooling process after whichexternal cooling blankets 102 or other hypothermia producing therapies can be implemented, as shown inFIG. 10 . - In yet further embodiments, the IV fluid may be cooled with an ultrasonic refrigeration method. Or the tissues may be cooled directly via ultrasonic or other energy transmission means. One such example involves the use of an ultra-sonic cooling incorporated into a helmet for a neuro-protective device. These focused cooling technologies may be used to target any organ, though, including the heart, brain, liver, kidneys, etc., or may be used to cool the entire body.
- Tissue penetration and placement of the fluid delivery member can be achieved in any manner known in the art, such as that described in US 2007/0106247, which has been incorporated herein by reference. The device may then report entry to the user and/or automatically initiate therapy.
- To provide lumens for fluid infusion and for fluid extraction, a dual lumen catheter may be used.
FIGS. 11 and 12 show one embodiment in which initial access through theabdominal wall 113 to thecavity 112 is obtained with a fill trocar, catheter orneedle 110.Infusion tubing 116 leads from a fluid source (not shown to a cap orfluid seal 117. Anextraction catheter 118 may be inserted throughcap 117 to extract fluid from the cavity, e.g., after a rapid infusion phase of the therapy. In some embodiments, thedistal end 119 and inlet port of theextraction catheter 118 may be weighted to ensure that it lies in the most dependent portion of theperitoneal cavity 112.
Claims (16)
1. A therapeutic fluid infusion and extraction system, comprising:
a fluid source;
a fluid delivery member adapted to be inserted into a peritoneal cavity of a patient, the fluid delivery member being configured to infuse fluid from the fluid source into the peritoneal cavity and to remove fluid from the peritoneal cavity; and
a cavity pressure limiter adapted to limit fluid pressure within the peritoneal cavity without providing feedback control to the fluid source.
2. The system of claim 1 wherein the cavity pressure limiter comprises a pressure relief valve configured to control flow of fluid through the fluid extraction member.
3. The system of claim 2 wherein the pressure relief valve is configured to open when the fluid pressure within the peritoneal cavity reaches a predetermined pressure.
4. The system of claim 1 further comprising an outlet port disposed in the fluid delivery member, the outlet port being configured to automatically commence infusion of fluid when the fluid delivery member enters the peritoneal cavity.
5. The system of claim 1 further comprising a weight disposed near an inlet port.
6. The system of claim 1 wherein the fluid source comprises a pump and the cavity pressure limiter comprising a torque limiter in the pump.
7. The system of claim 6 wherein the torque limiter comprises a clutch plate.
8. The system of claim 1 wherein the fluid delivery member comprises a multi-lumen catheter.
9. The system of claim 1 further comprising a heat exchange element thermally coupled to the fluid delivery member.
10. The system of claim 9 wherein the heat exchange element is configured to cool the fluid from the fluid source.
11. The system of claim 9 wherein the heat exchange element is configured to heat the fluid from the fluid source.
12. The system of claim 1 wherein the fluid source is filled with a hypothermia fluid.
13. The system of claim 1 further comprising a patient temperature sensor.
14. The system of claim 13 wherein the temperature sensor is mounted on an endotracheal cuff.
15. The system of claim 13 wherein the temperature sensor is mounted on an esophageal catheter.
16. The system of claim 13 wherein the temperature sensor is mounted on a bladder catheter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/860,426 US20130226077A1 (en) | 2007-07-09 | 2013-04-10 | Hypothermia Devices and Methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95871707P | 2007-07-09 | 2007-07-09 | |
US12/169,566 US8439960B2 (en) | 2007-07-09 | 2008-07-08 | Hypothermia devices and methods |
US13/860,426 US20130226077A1 (en) | 2007-07-09 | 2013-04-10 | Hypothermia Devices and Methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/169,566 Continuation US8439960B2 (en) | 2007-07-09 | 2008-07-08 | Hypothermia devices and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130226077A1 true US20130226077A1 (en) | 2013-08-29 |
Family
ID=39971084
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/169,566 Active 2032-01-05 US8439960B2 (en) | 2007-07-09 | 2008-07-08 | Hypothermia devices and methods |
US13/860,426 Abandoned US20130226077A1 (en) | 2007-07-09 | 2013-04-10 | Hypothermia Devices and Methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/169,566 Active 2032-01-05 US8439960B2 (en) | 2007-07-09 | 2008-07-08 | Hypothermia devices and methods |
Country Status (6)
Country | Link |
---|---|
US (2) | US8439960B2 (en) |
EP (1) | EP2167000A1 (en) |
JP (1) | JP5410423B2 (en) |
AU (1) | AU2008275158A1 (en) |
CA (1) | CA2693774A1 (en) |
WO (1) | WO2009009540A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015035315A2 (en) | 2013-09-08 | 2015-03-12 | Qool Therapeutics, Inc. | Temperature measurment and feedback for therapeutic hypothermia |
CN104792429A (en) * | 2015-03-30 | 2015-07-22 | 哈尔滨医科大学 | Device for measuring temperature of exhaled gas of mechanical ventilation patient |
US20170100281A1 (en) * | 2009-02-26 | 2017-04-13 | Advanced Cooling Therapy, Inc. | Treatment of ischemia-reperfusion injury by controlling patient temperature |
US9757272B2 (en) | 2004-01-22 | 2017-09-12 | Qool Therapeutics, Inc. | Respiratory system for inducing therapeutic hypothermia |
US9931044B2 (en) | 2010-07-09 | 2018-04-03 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
US10363162B2 (en) | 2009-02-26 | 2019-07-30 | Advanced Cooling Therapy, Inc. | Devices and methods for controlling patient temperature |
US11020269B2 (en) | 2015-02-23 | 2021-06-01 | Qool Therapeutics, Inc. | Systems and methods for endotracheal delivery of frozen particles |
US11800992B2 (en) | 2007-04-05 | 2023-10-31 | Theranova, Llc | Device and method for safe access and automated therapy |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2411569A1 (en) * | 2002-11-12 | 2004-05-12 | Ross E. Mantle | Medical device for the extravascular recirculation of fluid in body cavities at controlled temperature and pressure |
EP3064242A1 (en) | 2003-04-28 | 2016-09-07 | Advanced Circulatory Systems Inc. | Ventilator and methods for treating head trauma and low blood circulation |
US20070051409A1 (en) | 2005-09-02 | 2007-03-08 | Belmont Instrument Corporation | Pressure responsive fluid flow control valves |
US20180311071A1 (en) | 2005-10-21 | 2018-11-01 | Daniel R. BURNETT | Method and apparatus for peritoneal oxygenation |
US8151790B2 (en) | 2007-04-19 | 2012-04-10 | Advanced Circulatory Systems, Inc. | Volume exchanger valve system and method to increase circulation during CPR |
US9352111B2 (en) | 2007-04-19 | 2016-05-31 | Advanced Circulatory Systems, Inc. | Systems and methods to increase survival with favorable neurological function after cardiac arrest |
US7819835B2 (en) | 2007-08-07 | 2010-10-26 | Belmont Instrument Corporation | Hyperthermia, system, method and components |
US11000407B2 (en) | 2007-08-07 | 2021-05-11 | Belmont Instrument, Llc | Hyperthermia, system, method, and components |
US8529612B2 (en) * | 2008-06-24 | 2013-09-10 | Mayo Foundation For Medical Education And Research | Gastroduodenal balloon tubes and methods for use in localized hypothermia |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US20100121159A1 (en) * | 2008-11-07 | 2010-05-13 | Daniel Rogers Burnett | Devices and Methods for Monitoring Core Temperature and an Intraperitoneal Parameter |
JP2012517298A (en) * | 2009-02-06 | 2012-08-02 | ベロメディックス,インク | Method and apparatus for introducing hypothermia therapy |
US8608696B1 (en) | 2009-02-24 | 2013-12-17 | North Carolina State University | Rapid fluid cooling devices and methods for cooling fluids |
US9326890B2 (en) | 2009-02-26 | 2016-05-03 | Advanced Cooling Therapy, Inc. | Devices and methods for controlling patient temperature |
AU2010256778A1 (en) | 2009-06-01 | 2011-12-22 | Theranova, Llc | Continuous blood glucose monitor |
WO2010141500A1 (en) | 2009-06-01 | 2010-12-09 | Theranova, Llc | Methods and apparatus for treatment of a body cavity or lumen |
US9724266B2 (en) | 2010-02-12 | 2017-08-08 | Zoll Medical Corporation | Enhanced guided active compression decompression cardiopulmonary resuscitation systems and methods |
US20120203147A1 (en) * | 2010-07-02 | 2012-08-09 | ResQSystems, Inc. | Vasodilator-enhanced cardiopulmonary resuscitation |
US10737014B2 (en) * | 2010-11-09 | 2020-08-11 | Femasys Inc. | Methods and devices for managing fluid pressure |
EP2670328B1 (en) | 2011-02-01 | 2019-10-16 | Channel Medsystems, Inc. | Apparatus for cyrogenic treatment of a body cavity or lumen |
US9439804B2 (en) * | 2011-03-03 | 2016-09-13 | Renaud Tissier | Method and system for treatment of a body of a mammal in cardiac arrest |
EP2683422B1 (en) | 2011-03-07 | 2019-05-08 | Potrero Medical, Inc. | Sensing foley catheter |
WO2014099527A1 (en) | 2012-12-17 | 2014-06-26 | Theranova, Llc | Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis |
WO2013016437A2 (en) | 2011-07-25 | 2013-01-31 | Neurosave, Inc. | Non-invasive systems, devices, and methods for selective brain cooling |
JP6150802B2 (en) * | 2011-09-05 | 2017-06-21 | クール セラピューティクス, インコーポレイテッド | Stomach, skin, and peritoneal delivery of frozen mist to induce hyperthermia |
US9238115B2 (en) | 2011-12-19 | 2016-01-19 | ResQSystems, Inc. | Systems and methods for therapeutic intrathoracic pressure regulation |
JP2013141480A (en) * | 2012-01-10 | 2013-07-22 | Nippon Koden Corp | Body temperature maintaining apparatus |
US9811634B2 (en) | 2013-04-25 | 2017-11-07 | Zoll Medical Corporation | Systems and methods to predict the chances of neurologically intact survival while performing CPR |
US20140358047A1 (en) | 2013-05-30 | 2014-12-04 | ResQSystems, Inc. | End-tidal carbon dioxide and amplitude spectral area as non-invasive markers of coronary perfusion pressure and arterial pressure |
US9895183B2 (en) | 2013-09-17 | 2018-02-20 | Channel Medsystems, Inc. | Liner for cryogenic treatment systems |
US10265495B2 (en) | 2013-11-22 | 2019-04-23 | Zoll Medical Corporation | Pressure actuated valve systems and methods |
US10610279B2 (en) | 2014-04-10 | 2020-04-07 | Channel Medsystems, Inc. | Apparatus and methods for regulating cryogenic treatment |
US11504322B2 (en) | 2014-08-28 | 2022-11-22 | The General Hospital Corporation | Injectable slurries and methods of manufacturing the same |
EP4176885A1 (en) | 2014-08-28 | 2023-05-10 | The General Hospital Corporation | Compositions and methods for treatment of neurological disorders |
US11471401B2 (en) | 2014-08-28 | 2022-10-18 | The General Hospital Corporation | Injectable slurries and methods of manufacturing the same |
CN114576893A (en) | 2016-02-26 | 2022-06-03 | 通用医疗公司 | Medical ice slurry production and delivery system and method |
US10507292B2 (en) | 2016-11-30 | 2019-12-17 | Belmont Instrument, Llc | Rapid infuser with vacuum release valve |
US10137257B2 (en) | 2016-11-30 | 2018-11-27 | Belmont Instrument, Llc | Slack-time heating system for blood and fluid warming |
US10485936B2 (en) | 2016-11-30 | 2019-11-26 | Belmont Instrument, Llc | Rapid infuser with advantageous flow path for blood and fluid warming |
US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
WO2019183464A1 (en) | 2018-03-22 | 2019-09-26 | Cryolife, Inc. | Central nervous system localized hypothermia apparatus and methods |
US11399882B2 (en) | 2020-03-27 | 2022-08-02 | EyeCool Therapeutics, Inc. | Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry |
IL299718A (en) | 2020-07-10 | 2023-03-01 | C Change Surgical Llc | Injectable slush feed supply |
US11241330B1 (en) | 2021-04-02 | 2022-02-08 | Brixton Biosciences, Inc. | Apparatus for creation of injectable slurry |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6547811B1 (en) * | 1999-08-02 | 2003-04-15 | Arch Development Corporation | Method for inducing hypothermia |
US20030199824A1 (en) * | 2002-04-23 | 2003-10-23 | Mahoney Derek Dwayne | Dispenser for patient infusion device |
US20060161107A1 (en) * | 2002-11-12 | 2006-07-20 | Mantle Ross E | Device for the extravascular recirculation of liquid in body cavities |
Family Cites Families (247)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2078786A (en) * | 1934-12-17 | 1937-04-27 | Wood Glen Mason | Applicator and control means therefor |
US3042042A (en) * | 1958-03-14 | 1962-07-03 | Blanck Joachim Hillard | Stomach pump |
US3505988A (en) * | 1967-04-11 | 1970-04-14 | Norman Deane | Prosthesis for chronic access to the peritoneum |
US3698396A (en) | 1970-12-04 | 1972-10-17 | Abbott Lab | Catheter assembly for peritoneal cavity insertion |
US3927980A (en) | 1973-08-22 | 1975-12-23 | Baxter Laboratories Inc | Oxygen overpressure protection system for membrane-type blood oxygenators |
SE436660B (en) | 1979-01-25 | 1985-01-14 | Gambro Crafon Ab | DEVICE FOR SEATING TEMPERATURE AND SETTING ASTADCOM A DEVICE FOR SEATING TEMPERATURE |
US4356826A (en) | 1979-05-09 | 1982-11-02 | Olympus Optical Co., Ltd. | Stabbing apparatus for diagnosis of living body |
US4657532A (en) | 1985-07-19 | 1987-04-14 | Thomas Jefferson University | Intra-peritoneal perfusion of oxygenated fluorocarbon |
US4445500A (en) * | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4424806A (en) * | 1981-03-12 | 1984-01-10 | Physio-Control Corporation | Automated ventilation, CPR, and circulatory assistance apparatus |
US4413633A (en) | 1981-06-01 | 1983-11-08 | Yanda Roman L | Method and apparatus for monitoring body conditions |
US4450841A (en) * | 1982-03-03 | 1984-05-29 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4535773A (en) | 1982-03-26 | 1985-08-20 | Inbae Yoon | Safety puncturing instrument and method |
US4883459A (en) | 1983-07-29 | 1989-11-28 | Reynaldo Calderon | Retrograde perfusion |
US4497324A (en) * | 1983-10-03 | 1985-02-05 | American Hospital Supply Corporation | Temperature monitoring catheter |
IL78756A0 (en) * | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Catheter and probe |
US4808157A (en) * | 1987-07-13 | 1989-02-28 | Neuro Delivery Technology, Inc. | Multi-lumen epidural-spinal needle |
US4919134A (en) * | 1987-07-31 | 1990-04-24 | Becton, Dickinson And Company | Thermoelectric chiller and automatic syringe |
US4904237A (en) * | 1988-05-16 | 1990-02-27 | Janese Woodrow W | Apparatus for the exchange of cerebrospinal fluid and a method of treating brain and spinal cord injuries |
US5249585A (en) | 1988-07-28 | 1993-10-05 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US5108364A (en) * | 1989-02-16 | 1992-04-28 | Sumitomo Bakelte Company Limited | Monitoring catheter for medical use |
US5141493A (en) | 1990-01-26 | 1992-08-25 | Sarcos Group | Peritoneal dialysis system |
US5149321A (en) | 1990-10-10 | 1992-09-22 | Klatz Ronald M | Brain resuscitation device and method for performing the same |
US5584804A (en) | 1990-10-10 | 1996-12-17 | Life Resuscitation Technologies, Inc. | Brain resuscitation and organ preservation device and method for performing the same |
US5261891A (en) | 1991-01-15 | 1993-11-16 | Ethicon, Inc. | Trocar |
US5122267A (en) * | 1991-01-24 | 1992-06-16 | Oceanic Systems, Inc. | Foam fractionation filter |
US5693017A (en) | 1991-02-14 | 1997-12-02 | Wayne State University | Apparatus and method of delivery of gas-supersaturated solutions to a delivery site |
CA2042449C (en) | 1991-05-13 | 1997-02-04 | Joseph E. Dadson | Peritoneal dialysis apparatus |
US5245367A (en) | 1991-11-12 | 1993-09-14 | David Miller | Annular mask contact lenses |
KR0145453B1 (en) | 1992-01-21 | 1998-07-01 | 알렌 제이 | Electrosurgical trocar control device |
US5709661A (en) * | 1992-04-14 | 1998-01-20 | Endo Sonics Europe B.V. | Electronic catheter displacement sensor |
AU659261B2 (en) | 1992-06-19 | 1995-05-11 | Conmed Corporation | Electrosurgical trocar assembly |
FR2693179B1 (en) | 1992-07-03 | 1994-10-14 | Martin Sa | Sheet retainer for a stacking magazine. |
US5282962A (en) * | 1992-07-17 | 1994-02-01 | Chen Chi Der | Protein skimmer and power head thereof |
US5354277A (en) | 1992-09-04 | 1994-10-11 | Biocontrol Technology, Inc. | Specialized perfusion protocol for whole-body hyperthermia |
US5837003A (en) | 1993-02-10 | 1998-11-17 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
US6110168A (en) | 1993-02-10 | 2000-08-29 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications |
US6620188B1 (en) | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
JPH08508176A (en) | 1993-04-09 | 1996-09-03 | アプライド メディカル リソーセス コーポレイション | Surgical trocar with cut-off circuit |
JP3387602B2 (en) | 1993-12-27 | 2003-03-17 | テルモ株式会社 | Intraperitoneal indwelling catheter |
US5478329A (en) | 1994-05-06 | 1995-12-26 | Ternamian; Artin M. | Trocarless rotational entry cannula |
US5623940A (en) * | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
US5554280A (en) | 1995-05-15 | 1996-09-10 | Loehr; Gary | Filter system |
US5562821A (en) | 1995-07-21 | 1996-10-08 | Commonwealth Of Puerto Rico | Foam fractionator |
US5730720A (en) * | 1995-08-18 | 1998-03-24 | Ip Scientific, Inc. | Perfusion hyperthermia treatment system and method |
US5755756A (en) * | 1995-09-15 | 1998-05-26 | Freedman, Jr.; Robert J. | Hypothermia-inducing resuscitation unit |
US5665227A (en) | 1995-11-29 | 1997-09-09 | Watt; Ronald | Dual-flow protein skimmer |
US6066163A (en) * | 1996-02-02 | 2000-05-23 | John; Michael Sasha | Adaptive brain stimulation method and system |
JP3526690B2 (en) * | 1996-04-26 | 2004-05-17 | 富雄 太田 | Extracorporeal circulation device for separate cooling method |
US5758643A (en) | 1996-07-29 | 1998-06-02 | Via Medical Corporation | Method and apparatus for monitoring blood chemistry |
KR100378358B1 (en) | 1996-07-30 | 2003-05-27 | 삼성전자주식회사 | Apparatus for measuring body temperature |
WO1998017333A2 (en) * | 1996-10-22 | 1998-04-30 | Hemocleanse, Inc. | Continuous flow-through peritoneal dialysis (cfpd) method with control of intraperitoneal pressure |
US6019729A (en) * | 1996-11-15 | 2000-02-01 | Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho | Sensor mechanism-equipped catheter |
CA2285342C (en) | 1997-04-01 | 2007-06-19 | Axel Muntermann | Method and device for detecting catheter-tissue contact and interaction with tissue during catheter ablation |
US7264680B2 (en) | 1997-05-09 | 2007-09-04 | Semitool, Inc. | Process and apparatus for treating a workpiece using ozone |
JPH11221229A (en) * | 1997-09-24 | 1999-08-17 | Eclipse Surgical Technol Inc | Catheter |
US5916153A (en) * | 1997-10-27 | 1999-06-29 | Rhea, Jr.; W. Gardner | Multifunction catheter |
US6312452B1 (en) | 1998-01-23 | 2001-11-06 | Innercool Therapies, Inc. | Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device |
WO1999037335A1 (en) | 1998-01-23 | 1999-07-29 | Hemotherm, Inc. | Apparatuses and processes for whole-body hyperthermia |
US7458984B2 (en) | 1998-01-23 | 2008-12-02 | Innercool Therapies, Inc. | System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm |
US7371254B2 (en) * | 1998-01-23 | 2008-05-13 | Innercool Therapies, Inc. | Medical procedure |
US6261312B1 (en) * | 1998-06-23 | 2001-07-17 | Innercool Therapies, Inc. | Inflatable catheter for selective organ heating and cooling and method of using the same |
US6991645B2 (en) | 1998-01-23 | 2006-01-31 | Innercool Therapies, Inc. | Patient temperature regulation method and apparatus |
US6464716B1 (en) * | 1998-01-23 | 2002-10-15 | Innercool Therapies, Inc. | Selective organ cooling apparatus and method |
US6558412B2 (en) | 1998-01-23 | 2003-05-06 | Innercool Therapies, Inc. | Selective organ hypothermia method and apparatus |
US6471717B1 (en) * | 1998-03-24 | 2002-10-29 | Innercool Therapies, Inc. | Selective organ cooling apparatus and method |
US6974463B2 (en) | 1999-02-09 | 2005-12-13 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6149624A (en) * | 1998-02-05 | 2000-11-21 | Mcshane; Richard Houston | Apparatus and method for the rapid induction of hypothermic brain preservation |
US6599312B2 (en) * | 1998-03-24 | 2003-07-29 | Innercool Therapies, Inc. | Isolated selective organ cooling apparatus |
US6645234B2 (en) | 1998-04-21 | 2003-11-11 | Alsius Corporation | Cardiovascular guiding catheter with heat exchange properties and methods of use |
US6581403B2 (en) | 2001-09-25 | 2003-06-24 | Alsius Corporation | Heating/cooling system for indwelling heat exchange catheter |
US6716236B1 (en) * | 1998-04-21 | 2004-04-06 | Alsius Corporation | Intravascular catheter with heat exchange element having inner inflation element and methods of use |
US6149670A (en) | 1999-03-11 | 2000-11-21 | Alsius Corporation | Method and system for treating cardiac arrest using hypothermia |
US6682551B1 (en) * | 1999-03-11 | 2004-01-27 | Alsius Corporation | Method and system for treating cardiac arrest using hypothermia |
US6520933B1 (en) * | 1998-04-21 | 2003-02-18 | Alsius Corporation | Central venous line cooling catheter having a spiral-shaped heat exchange member |
US6368304B1 (en) * | 1999-02-19 | 2002-04-09 | Alsius Corporation | Central venous catheter with heat exchange membrane |
US7255709B2 (en) | 1998-04-21 | 2007-08-14 | Alsius Corporation | Intravascular heat exchange catheter with temperature sensor |
US6126684A (en) | 1998-04-21 | 2000-10-03 | The Regents Of The University Of California | Indwelling heat exchange catheter and method of using same |
US6419643B1 (en) | 1998-04-21 | 2002-07-16 | Alsius Corporation | Central venous catheter with heat exchange properties |
US6530946B1 (en) * | 1998-04-21 | 2003-03-11 | Alsius Corporation | Indwelling heat exchange heat pipe catheter and method of using same |
US6338727B1 (en) * | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US7287398B2 (en) | 2001-09-25 | 2007-10-30 | Alsius Corporation | Heating/cooling system for indwelling heat exchange catheter |
US6458150B1 (en) | 1999-02-19 | 2002-10-01 | Alsius Corporation | Method and apparatus for patient temperature control |
US6873156B2 (en) * | 1998-05-06 | 2005-03-29 | Insight Neuroimaging Systems, Llc | Method and apparatus for performing neuroimaging |
IL124963A0 (en) | 1998-06-17 | 1999-01-26 | Abramovitch Aharon | Tracheal intubation stylet and improved methods of intubation and of lung function physiologic research and of functional pulmunologic diagnosis |
US6175688B1 (en) * | 1998-07-10 | 2001-01-16 | Belmont Instrument Corporation | Wearable intravenous fluid heater |
US6450990B1 (en) | 1998-08-13 | 2002-09-17 | Alsius Corporation | Catheter with multiple heating/cooling fibers employing fiber spreading features |
US6673098B1 (en) * | 1998-08-24 | 2004-01-06 | Radiant Medical, Inc. | Disposable cassette for intravascular heat exchange catheter |
US6610083B2 (en) | 1998-08-24 | 2003-08-26 | Radiant Medical, Inc. | Multiple lumen heat exchange catheters |
US6620189B1 (en) | 2000-02-28 | 2003-09-16 | Radiant Medical, Inc. | Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter |
US6188930B1 (en) * | 1998-09-11 | 2001-02-13 | Medivance Incorporated | Method and apparatus for providing localized heating of the preoptic anterior hypothalamus |
US6117076A (en) | 1998-09-21 | 2000-09-12 | Belmont Instruments Corporation | Patient monitoring system and method |
US6146411A (en) | 1998-12-24 | 2000-11-14 | Alsius Corporation | Cooling system for indwelling heat exchange catheter |
US6197045B1 (en) * | 1999-01-04 | 2001-03-06 | Medivance Incorporated | Cooling/heating pad and system |
US6375674B1 (en) * | 1999-01-04 | 2002-04-23 | Medivance, Inc. | Cooling/heating pad and system |
US6743218B2 (en) | 1999-01-15 | 2004-06-01 | Cathlogic, Inc. | Retractable catheter systems and associated methods |
US6635053B1 (en) | 1999-01-25 | 2003-10-21 | Cryocath Technologies Inc. | Cooling system |
US6592577B2 (en) | 1999-01-25 | 2003-07-15 | Cryocath Technologies Inc. | Cooling system |
US6436295B2 (en) | 1999-02-11 | 2002-08-20 | Jason Kim | Protein skimmer |
EP1029520B1 (en) | 1999-02-19 | 2002-08-14 | Alsius Corporation | Central venous line catheter having temperature control system |
US6719724B1 (en) * | 1999-02-19 | 2004-04-13 | Alsius Corporation | Central venous line catheter having multiple heat exchange elements and multiple infusion lumens |
US6299599B1 (en) | 1999-02-19 | 2001-10-09 | Alsius Corporation | Dual balloon central venous line catheter temperature control system |
US6405080B1 (en) * | 1999-03-11 | 2002-06-11 | Alsius Corporation | Method and system for treating cardiac arrest |
US6554797B1 (en) * | 1999-02-19 | 2003-04-29 | Alsius Corporation | Method and system for patient temperature management and central venous access |
US6582398B1 (en) | 1999-02-19 | 2003-06-24 | Alsius Corporation | Method of managing patient temperature with a heat exchange catheter |
US6585692B1 (en) | 1999-02-19 | 2003-07-01 | Alsius Corporation | Method and system for patient temperature management and central venous access |
US6254567B1 (en) | 1999-02-26 | 2001-07-03 | Nxstage Medical, Inc. | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
US6217552B1 (en) * | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
US6019783A (en) * | 1999-03-02 | 2000-02-01 | Alsius Corporation | Cooling system for therapeutic catheter |
US6460544B1 (en) | 1999-03-11 | 2002-10-08 | Alsius Corporation | Method and apparatus for establishing and maintaining therapeutic hypothemia |
US6290717B1 (en) | 1999-03-31 | 2001-09-18 | Alsius Corporation | Temperature probe and interconnect cable for hypothermia catheter temperature feedback |
US6579496B1 (en) | 1999-05-25 | 2003-06-17 | Viacirq, Inc. | Apparatus for implementing hyperthermia |
AU777801B2 (en) | 1999-05-25 | 2004-10-28 | Viacirq, Inc. | Hyperthermia method and apparatus |
US6165207A (en) | 1999-05-27 | 2000-12-26 | Alsius Corporation | Method of selectively shaping hollow fibers of heat exchange catheter |
WO2000072779A2 (en) | 1999-05-27 | 2000-12-07 | Alsius Corporation | Apparatus and method for advancing cooling catheter |
US6536260B2 (en) | 1999-06-24 | 2003-03-25 | Datascope Investment Corp. | Balloon catheter leak detection method and apparatus |
WO2001003606A2 (en) | 1999-07-08 | 2001-01-18 | Alsius Corporation | Operational enhancements for using cooling catheters |
JP2001029459A (en) | 1999-07-19 | 2001-02-06 | Tomio Ota | Liquid supply system |
US6287326B1 (en) | 1999-08-02 | 2001-09-11 | Alsius Corporation | Catheter with coiled multi-lumen heat transfer extension |
US7422601B2 (en) * | 1999-08-02 | 2008-09-09 | University Of Chicago Office Of Technology Transfer | Method for inducing hypothermia |
US6231594B1 (en) * | 1999-08-11 | 2001-05-15 | Radiant Medical, Inc. | Method of controlling body temperature while reducing shivering |
US6685724B1 (en) | 1999-08-24 | 2004-02-03 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
AU7351200A (en) | 1999-09-03 | 2001-04-10 | Alsius Corporation | Method and system for treating high intracranial pressure using hypothermia |
US6447474B1 (en) | 1999-09-15 | 2002-09-10 | Alsius Corporation | Automatic fever abatement system |
US6554791B1 (en) * | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
US20050154370A1 (en) | 1999-10-29 | 2005-07-14 | Medtronic, Inc. | Methods and systems for providing therapies into the pericardial space |
GB9926980D0 (en) | 1999-11-15 | 2000-01-12 | Medivance Instr Limited | Improved pneumatic device |
WO2001039819A2 (en) | 1999-12-03 | 2001-06-07 | Neuron Therapeutics, Inc. | Method and apparatus for closed recirculation of synthetic cerebrospinal fluid |
AU4713601A (en) | 1999-12-07 | 2001-06-18 | Alsius Corporation | Method and system for treating stroke using hypothermia |
AU4523301A (en) | 1999-12-14 | 2001-06-25 | Radiant Medical, Inc. | Method for reducing myocardial infarct by applicaton of intravascular hypothermia |
US6347633B1 (en) * | 2000-01-14 | 2002-02-19 | First Circle Medical, Inc. | Treatment of hepatitis C using hyperthermia |
US6497676B1 (en) | 2000-02-10 | 2002-12-24 | Baxter International | Method and apparatus for monitoring and controlling peritoneal dialysis therapy |
US6648906B2 (en) * | 2000-04-06 | 2003-11-18 | Innercool Therapies, Inc. | Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid |
US6592612B1 (en) | 2000-05-04 | 2003-07-15 | Cardeon Corporation | Method and apparatus for providing heat exchange within a catheter body |
US6726708B2 (en) * | 2000-06-14 | 2004-04-27 | Innercool Therapies, Inc. | Therapeutic heating and cooling via temperature management of a colon-inserted balloon |
US7010612B1 (en) * | 2000-06-22 | 2006-03-07 | Ubicom, Inc. | Universal serializer/deserializer |
WO2002026175A1 (en) | 2000-09-28 | 2002-04-04 | Alsius Corporation | Venous line catheter and method of operating the same |
US6819950B2 (en) | 2000-10-06 | 2004-11-16 | Alexander K. Mills | Method for noninvasive continuous determination of physiologic characteristics |
US6530945B1 (en) * | 2000-11-28 | 2003-03-11 | Alsius Corporation | System and method for controlling patient temperature |
US6602243B2 (en) | 2000-12-15 | 2003-08-05 | Alsius Corporation | Foley catheter having redundant temperature sensors and method |
US6699268B2 (en) * | 2000-12-15 | 2004-03-02 | Alsius Corporation | Radio frequency patient heating system |
US6529775B2 (en) * | 2001-01-16 | 2003-03-04 | Alsius Corporation | System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating |
WO2002058606A1 (en) | 2001-01-24 | 2002-08-01 | Alsius Corporation | Central venous catheter with heat exchange properties |
US6451045B1 (en) | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
US6572641B2 (en) * | 2001-04-09 | 2003-06-03 | Nxstage Medical, Inc. | Devices for warming fluid and methods of use |
US6641603B2 (en) | 2001-04-13 | 2003-11-04 | Alsius Corporation | Heat exchange catheter having helically wound reinforcement |
US6641602B2 (en) | 2001-04-13 | 2003-11-04 | Alsius Corporation | Method and device including a colo-rectal heat exchanger |
US6709448B2 (en) * | 2001-04-13 | 2004-03-23 | Alsius Corporation | Open core heat exchange catheter, system and method |
US6461379B1 (en) | 2001-04-30 | 2002-10-08 | Medivance, Incorporated | Localized bodily cooling/heating apparatus and method |
US7756582B2 (en) | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
US6752786B2 (en) | 2001-05-31 | 2004-06-22 | Radiant Medical, Inc. | Moving heat exchange catheter system |
US6706060B2 (en) * | 2001-06-05 | 2004-03-16 | Alsius Corporation | Heat exchange catheter |
US6733517B1 (en) * | 2001-06-13 | 2004-05-11 | Alsius Corporation | Angling introducer sheath for catheter having temperature control system |
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
WO2003008924A1 (en) * | 2001-07-18 | 2003-01-30 | Rosenblatt Peter L | Detecting or preventing tissue damage |
US6680027B2 (en) * | 2001-07-30 | 2004-01-20 | Princeton Biomeditech Corporation | Fluid sample collection and isolation cup |
US6676409B2 (en) * | 2001-08-01 | 2004-01-13 | Medivance Instruments Limited | Dental tool |
US6692519B1 (en) * | 2001-08-06 | 2004-02-17 | Radiant Medical, Inc. | Use of endovascular hypothermia in organ and/or tissue transplantations |
AU2002326640B2 (en) | 2001-08-15 | 2008-05-01 | Zoll Circulation, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6607517B1 (en) * | 2001-08-24 | 2003-08-19 | Radiant Medical, Inc. | Method of inotropic treatment of heart disease using hypothermia |
US6911014B2 (en) | 2001-10-05 | 2005-06-28 | Medical Components, Inc. | Continuous flow peritoneal dialysis catheter |
US6660027B2 (en) | 2001-10-11 | 2003-12-09 | Medivance Incorporated | Patient temperature control system with fluid preconditioning |
US6818012B2 (en) | 2001-10-11 | 2004-11-16 | Medivance, Incorporated | Patient temperature control system with fluid temperature response |
US6699267B2 (en) * | 2001-10-11 | 2004-03-02 | Medivance Incorporated | Patient temperature control system with fluid temperature response |
US7378856B2 (en) * | 2001-10-24 | 2008-05-27 | Pressure Profile Systems | Array sensor electronics |
US6800068B1 (en) | 2001-10-26 | 2004-10-05 | Radiant Medical, Inc. | Intra-aortic balloon counterpulsation with concurrent hypothermia |
MXPA04004246A (en) | 2001-11-01 | 2004-09-10 | Scott Lab Inc | User interface for sedation and analgesia delivery systems and methods. |
US6807444B2 (en) | 2001-11-05 | 2004-10-19 | Hosheng Tu | Apparatus and methods for monitoring tissue impedance |
US6572640B1 (en) | 2001-11-21 | 2003-06-03 | Alsius Corporation | Method and apparatus for cardiopulmonary bypass patient temperature control |
AU2002362045A1 (en) | 2001-12-04 | 2003-06-17 | Minnesota High-Tech Resources, Llc | Breathable gas mixtures to change body temperature |
AU2002243488A1 (en) | 2002-01-09 | 2003-07-30 | Alsius Corporation | Method and system for therapeutic hypothermia |
US7077825B1 (en) | 2002-01-16 | 2006-07-18 | Radiant Medical, Inc. | Method for gastric cooling using balloon catheter |
US6669715B2 (en) | 2002-02-27 | 2003-12-30 | Medivance Incorporated | Medical thermal energy exchange pad |
US6799063B2 (en) | 2002-02-27 | 2004-09-28 | Medivance Incorporated | Temperature control pads with integral electrodes |
US6692518B2 (en) * | 2002-02-27 | 2004-02-17 | Medivance Incorporated | Patient temperature control system |
US6648905B2 (en) | 2002-02-27 | 2003-11-18 | Medivance Incorporated | Enhanced medical thermal energy exchange pad |
US6704590B2 (en) * | 2002-04-05 | 2004-03-09 | Cardiac Pacemakers, Inc. | Doppler guiding catheter using sensed blood turbulence levels |
US6685733B1 (en) * | 2002-04-10 | 2004-02-03 | Radiant Medical, Inc. | Methods and systems for reducing substance-induced renal damage |
US7144407B1 (en) | 2002-05-30 | 2006-12-05 | Alsius Corporation | Cardiovascular intra aortic balloon pump catheter with heat exchange function and methods of use |
US20030225393A1 (en) | 2002-05-31 | 2003-12-04 | Kimberly-Clark Worldwide, Inc. | Low profile transpyloric jejunostomy system and method to enable |
US6746474B2 (en) | 2002-05-31 | 2004-06-08 | Vahid Saadat | Apparatus and methods for cooling a region within the body |
US6852099B2 (en) | 2002-06-04 | 2005-02-08 | Baxter International Inc. | Device for controllably applying liquids to body surfaces |
US7666213B2 (en) * | 2002-07-11 | 2010-02-23 | Life Recovery Systems Hd, Llc | Apparatus for altering the body temperature of a patient |
US6878156B1 (en) | 2002-07-26 | 2005-04-12 | Alsius Corporation | Portable cooler for heat exchange catheter |
US6802855B2 (en) | 2002-08-08 | 2004-10-12 | Medivance Incorporated | Patient temperature control system connector apparatus |
US6827728B2 (en) | 2002-08-08 | 2004-12-07 | Medivance Incorporated | Patient temperature control system |
US6866638B2 (en) | 2002-08-12 | 2005-03-15 | Radiant Medical, Inc. | Temperature sensing system with retrograde sensor |
US20040039430A1 (en) | 2002-08-20 | 2004-02-26 | Xanodyne Pharmacal, Inc. | System and method using the rectal mucosal membrane for inducing hypothermia and warming |
US6796995B2 (en) | 2002-08-30 | 2004-09-28 | Alsius Corporation | Intravascular temperature control catheter |
US6749625B2 (en) | 2002-08-30 | 2004-06-15 | Alsius Corporation | Intravascular temperature control catheter |
AU2003270600B2 (en) * | 2002-09-12 | 2008-08-14 | Radiant Medical, Inc. | System and method for determining and controlling core body temperature |
EP1558130A4 (en) | 2002-10-15 | 2009-01-28 | Medtronic Inc | Screening techniques for management of a nervous system disorder |
US6887263B2 (en) * | 2002-10-18 | 2005-05-03 | Radiant Medical, Inc. | Valved connector assembly and sterility barriers for heat exchange catheters and other closed loop catheters |
US20040087606A1 (en) * | 2002-11-01 | 2004-05-06 | Voorhees Marc E. | Shivering suppression during cooling to lower body temperature |
US7276046B1 (en) | 2002-11-18 | 2007-10-02 | Biosynergy, Inc. | Liquid conductive cooling/heating device and method of use |
US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US7278984B2 (en) | 2002-12-31 | 2007-10-09 | Alsius Corporation | System and method for controlling rate of heat exchange with patient |
US7158838B2 (en) | 2003-01-31 | 2007-01-02 | Medtronic, Inc. | Arrangement for implanting a miniaturized cardiac lead having a fixation helix |
US7097657B2 (en) | 2003-02-18 | 2006-08-29 | Alsius Corporation | Dual IV bag arrangement for intravascular temperature control catheter cooling circuit |
US7300453B2 (en) | 2003-02-24 | 2007-11-27 | Innercool Therapies, Inc. | System and method for inducing hypothermia with control and determination of catheter pressure |
US7836881B2 (en) | 2003-04-28 | 2010-11-23 | Advanced Circulatory Systems, Inc. | Ventilator and methods for treating head trauma and low blood circulation |
US6893454B2 (en) * | 2003-04-28 | 2005-05-17 | Alsius Corporation | Intrarectal heat exchange catheter |
US7001418B2 (en) * | 2003-04-30 | 2006-02-21 | Alsius Corporation | Intravascular heat exchange catheter with insulated coolant tubes |
JP4291039B2 (en) | 2003-05-12 | 2009-07-08 | オリンパス株式会社 | Ultrasonic trocar puncture system |
US6872222B2 (en) * | 2003-05-19 | 2005-03-29 | Alsius Corporation | System and method for insulating skin from intravascular heat exchange catheter |
US6921198B2 (en) | 2003-06-12 | 2005-07-26 | Medivance Incorporated | Patient temperature repeating system and method |
US20050033391A1 (en) * | 2003-08-06 | 2005-02-10 | Alsius Corporation | System and method for treating cardiac arrest and myocardial infarction |
CA2536810A1 (en) * | 2003-08-25 | 2005-04-28 | Medivance Incorporated | Active body cooling with vasodilation to reduce body temperature |
US7270639B2 (en) * | 2003-10-14 | 2007-09-18 | Zoll Circulation, Inc. | Temperature regulation system for automatic chest compression housing |
US7693855B2 (en) | 2003-10-28 | 2010-04-06 | Media Cybernetics, Inc. | Method, system, and computer program product for managing data associated with a document stored in an electronic form |
JP4832763B2 (en) | 2004-01-20 | 2011-12-07 | エシコン・エンド−サージェリィ・インコーポレイテッド | Access medical device and medical procedure execution method |
US7318834B2 (en) | 2004-02-09 | 2008-01-15 | Philip Chidi Njemanze | Apparatus and method for hypothermia and rewarming by altering the temperature of the cerebrospinal fluid in the brain |
US20060064146A1 (en) * | 2004-09-17 | 2006-03-23 | Collins Kenneth A | Heating/cooling system for indwelling heat exchange catheter |
US6981945B1 (en) * | 2004-11-12 | 2006-01-03 | Artann Laboratories, Inc. | Colonoscope handgrip with force and torque monitor |
US7070612B1 (en) | 2005-02-23 | 2006-07-04 | Alsius Corporation | System and method for bringing hypothermia rapidly onboard |
US20060190066A1 (en) | 2005-02-23 | 2006-08-24 | Worthen William J | System and method for bringing hypothermia rapidly onboard |
US7425216B2 (en) | 2005-03-01 | 2008-09-16 | Alsius Corporation | System and method for treating cardiac arrest and myocardial infarction |
EP2305188B1 (en) * | 2005-04-27 | 2015-06-03 | ZOLL Circulation, Inc. | Apparatus for providing enhanced heat transfer from a body |
US7824436B2 (en) | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US20060276864A1 (en) | 2005-06-03 | 2006-12-07 | Alsius Corporation | Systems and methods for sensing patient temperature in temperature management system |
US7181927B2 (en) * | 2005-07-01 | 2007-02-27 | Alsius Corporation | Primary heat exchanger for patient temperature control |
US7771362B2 (en) * | 2005-08-01 | 2010-08-10 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
US7699799B2 (en) * | 2005-08-26 | 2010-04-20 | Ceeben Systems, Inc. | Ultrasonic material removal system for cardiopulmonary bypass and other applications |
US20070051409A1 (en) * | 2005-09-02 | 2007-03-08 | Belmont Instrument Corporation | Pressure responsive fluid flow control valves |
US20070093697A1 (en) | 2005-10-21 | 2007-04-26 | Theranova, Llc | Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature |
EP1937353B1 (en) * | 2005-10-21 | 2016-12-28 | Cincinnati Sub-Zero Products, Inc. | Patient temperature control system with variable gradient warming/cooling |
US20080200863A1 (en) | 2005-12-02 | 2008-08-21 | Cabochon Aesthetics, Inc. | Devices and methods for selectively lysing cells |
US20070196434A1 (en) | 2006-01-20 | 2007-08-23 | Oculus Innovative Sciences, Inc. | Methods of preventing or treating sinusitis with oxidative reductive potential water solution |
WO2007088547A2 (en) * | 2006-02-02 | 2007-08-09 | Tylerton International Inc. | Metabolic sink |
US20070225781A1 (en) | 2006-03-21 | 2007-09-27 | Nidus Medical, Llc | Apparatus and methods for altering temperature in a region within the body |
US7822485B2 (en) * | 2006-09-25 | 2010-10-26 | Zoll Circulation, Inc. | Method and apparatus for spinal cooling |
US20080119757A1 (en) * | 2006-11-21 | 2008-05-22 | Suzanne Winter | Temperature management system with wireless patient temperature sensor |
US7892270B2 (en) * | 2006-11-21 | 2011-02-22 | Zoll Circulation Inc. | Temperature management system and method for burn patients |
US20080154197A1 (en) | 2006-12-20 | 2008-06-26 | Joel Brian Derrico | System and method for regulating the temperature of a fluid injected into a patient |
JP2010522066A (en) | 2007-03-23 | 2010-07-01 | サーマル セラピューティク システムズ、インク. | Mobile thermotherapy device |
JP5259966B2 (en) | 2007-03-26 | 2013-08-07 | 株式会社ジェイ・エム・エス | Oral pressure measuring balloon and method for manufacturing the same |
US9333112B2 (en) | 2007-04-12 | 2016-05-10 | Medivance Incorporated | Sorption-based adhesive contact cooling apparatus and method |
US7819835B2 (en) | 2007-08-07 | 2010-10-26 | Belmont Instrument Corporation | Hyperthermia, system, method and components |
EP3677228A1 (en) * | 2007-10-12 | 2020-07-08 | Medivance Incorporated | Improved system for patient temperature control |
ES2664241T3 (en) * | 2007-11-16 | 2018-04-18 | Medivance Incorporated | A patient's temperature response control system and method |
WO2009071098A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Use non-human mammal capable of perspiration for determining the effect of hypothermia inducing drugs in humans |
WO2009071095A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
WO2009071094A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination treatment of ischemic effects |
WO2009071097A1 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Use of hypothermia inducing drugs |
WO2009071096A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination of medical and physical cooling treatment of ischemic effects |
US7827005B2 (en) | 2008-04-21 | 2010-11-02 | Zoll Circulation, Inc. | System and method for testing heat exchange system for heat exchange catheter |
-
2008
- 2008-07-08 EP EP08781520A patent/EP2167000A1/en not_active Withdrawn
- 2008-07-08 CA CA2693774A patent/CA2693774A1/en not_active Abandoned
- 2008-07-08 WO PCT/US2008/069441 patent/WO2009009540A1/en active Application Filing
- 2008-07-08 US US12/169,566 patent/US8439960B2/en active Active
- 2008-07-08 JP JP2010516202A patent/JP5410423B2/en not_active Expired - Fee Related
- 2008-07-08 AU AU2008275158A patent/AU2008275158A1/en not_active Abandoned
-
2013
- 2013-04-10 US US13/860,426 patent/US20130226077A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6547811B1 (en) * | 1999-08-02 | 2003-04-15 | Arch Development Corporation | Method for inducing hypothermia |
US20030199824A1 (en) * | 2002-04-23 | 2003-10-23 | Mahoney Derek Dwayne | Dispenser for patient infusion device |
US20060161107A1 (en) * | 2002-11-12 | 2006-07-20 | Mantle Ross E | Device for the extravascular recirculation of liquid in body cavities |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9757272B2 (en) | 2004-01-22 | 2017-09-12 | Qool Therapeutics, Inc. | Respiratory system for inducing therapeutic hypothermia |
US10893976B2 (en) | 2004-01-22 | 2021-01-19 | Qool Therapeutics, Inc. | Respiratory system for inducing therapeutic hypothermia |
US11800992B2 (en) | 2007-04-05 | 2023-10-31 | Theranova, Llc | Device and method for safe access and automated therapy |
US10413444B2 (en) * | 2009-02-26 | 2019-09-17 | Advanced Cooling Therapy, Inc. | Treatment of ischemia-reperfusion injury by controlling patient temperature |
US10716703B2 (en) | 2009-02-26 | 2020-07-21 | Advanced Cooling Therapy, Inc. | Devices and methods for controlling patient temperature |
US11633299B2 (en) | 2009-02-26 | 2023-04-25 | Advanced Cooling Therapy, Inc. | Methods for protecting esophageal tissue from thermal injury |
US20170100281A1 (en) * | 2009-02-26 | 2017-04-13 | Advanced Cooling Therapy, Inc. | Treatment of ischemia-reperfusion injury by controlling patient temperature |
US10363162B2 (en) | 2009-02-26 | 2019-07-30 | Advanced Cooling Therapy, Inc. | Devices and methods for controlling patient temperature |
US10568761B2 (en) | 2009-02-26 | 2020-02-25 | Advanced Cooling Therapy, Inc. | Methods for core body temperature management |
US9931044B2 (en) | 2010-07-09 | 2018-04-03 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
US10758135B2 (en) | 2010-07-09 | 2020-09-01 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
WO2015035315A2 (en) | 2013-09-08 | 2015-03-12 | Qool Therapeutics, Inc. | Temperature measurment and feedback for therapeutic hypothermia |
US10238831B2 (en) | 2013-09-08 | 2019-03-26 | Qool Therapeutics, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
US11357949B2 (en) | 2013-09-08 | 2022-06-14 | Pagonia Medical, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
EP3417839A1 (en) | 2013-09-08 | 2018-12-26 | Qool Therapeutics, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
US11020269B2 (en) | 2015-02-23 | 2021-06-01 | Qool Therapeutics, Inc. | Systems and methods for endotracheal delivery of frozen particles |
CN104792429A (en) * | 2015-03-30 | 2015-07-22 | 哈尔滨医科大学 | Device for measuring temperature of exhaled gas of mechanical ventilation patient |
Also Published As
Publication number | Publication date |
---|---|
AU2008275158A1 (en) | 2009-01-15 |
US20090076573A1 (en) | 2009-03-19 |
JP5410423B2 (en) | 2014-02-05 |
EP2167000A1 (en) | 2010-03-31 |
JP2010533039A (en) | 2010-10-21 |
US8439960B2 (en) | 2013-05-14 |
CA2693774A1 (en) | 2009-01-15 |
WO2009009540A1 (en) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8439960B2 (en) | Hypothermia devices and methods | |
US11311414B2 (en) | Apparatus and method for providing enhanced heat transfer from a body | |
AU2006304877B2 (en) | Method and apparatus for peritoneal hypothermia and/or resuscitation | |
US7241307B2 (en) | Method and apparatus for managing temperature in a patient | |
US20140031631A1 (en) | Method and Apparatus for Inducing Therapeutic Hypothermia | |
US20120095537A1 (en) | Method and Apparatus for Inducing Therapeutic Hypothermia | |
US10238533B2 (en) | Gastric, cutaneous, or peritoneal delivery of frozen mist to induce therapeutic hyperthermia | |
EP2178476B1 (en) | Methods and systems for inducing therapeutic hypothermia in a pre-hospital, field, or ambulance setting | |
US10016573B2 (en) | Systems and methods for body temperature management | |
US11446177B2 (en) | Method and apparatus for peritoneal oxygenation | |
US20160184505A1 (en) | Patient warming system | |
KR20220072853A (en) | Infusion catheters and methods of use | |
US20230099428A1 (en) | Liquid Ventilation System | |
CN115531081A (en) | Spinal cord cooling system | |
US20080177360A1 (en) | Patient warming system | |
AU2013205065A1 (en) | Method and apparatus for peritoneal hypothermia and/or resuscitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VELOMEDIX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BURNETT, DANIEL ROGERS;HALL, GREGORY W.;SIGNING DATES FROM 20080710 TO 20080716;REEL/FRAME:031726/0475 |
|
AS | Assignment |
Owner name: THERANOVA, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VELOMEDIX, INC.;REEL/FRAME:035551/0729 Effective date: 20140617 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |